Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children

Brodie, 1956, A Concept for a Role of Serotonin and Norepinephrine as Chemical Mediators in the Brain, Ann. New York Acad. Sc., 66, 631, 10.1111/j.1749-6632.1957.tb40753.x

Wooley, 1958, Serotonin in Mental Disorders, in The Brain and Human Behavior, A. Res. Nerv. & Ment. Dis. Proc., 36, 381

Marrazzi, 1960, The Action of Psychotogens and a Neurophysiological Theory of Hallucination, Am. J. Psychiat., 116, 911, 10.1176/ajp.116.10.911

Stacey, 1959, 5-Hydroxytryptamine and Other Pharmacologically Active Substances in the Central Nervous System, Acta physiol. et pharmacol. neerl., 8, 222

Giarman, 1959, Neurohumors in the Brain, Yale J. Biol. & Med., 32, 73

Crossland, 1960, Chemical Transmission in the Central Nervous System, J. Pharm. & Pharmacol., 12, 1, 10.1111/j.2042-7158.1960.tb12627.x

Feldstein, 1959, Blood and Urinary Serotonin and 5-HIAA Levels in Schizophrenic Subjects and Normal Subjects, J. Nerv. & Ment. Dis., 129, 62, 10.1097/00005053-195907000-00007

Kety, 1959, Biochemical Theories of Schizophrenia, Science, 129, 1590, 10.1126/science.129.3363.1590

Sjoerdsma, 1959, Serotonin, New England J. Med., 261, 231, 10.1056/NEJM195907302610505

Pare, 1957, 5-Hydroxytryptamine Deficiency in Phenylketonuria, Lancet, 1, 551, 10.1016/S0140-6736(57)90920-0

Pare, 1958, Decreased 5-Hydroxytryptophan Decarboxylase Activity in Phenylketonuria, Lancet, 2, 1099, 10.1016/S0140-6736(58)92471-1

Pare, 1959, The Relationship Between Decreased 5-Hydroxyindole Metabolism and Mental Defect in Phenylketonuria, Arch. Dis. Childhood, 34, 422, 10.1136/adc.34.177.422

Sandler, M.: Personal communication, 1960.

Sutton, 1958, Abnormal Amino Acid Metabolism in a Case Suggesting Autism, A. M. A. J. Dis. Child., 96, 23

Shaw, 1959, Metabolic Studies in Childhood Schizophrenia, Arch. Gen. Psychiat., 1, 366, 10.1001/archpsyc.1959.03590040036003

Schain, 1960, Infantile Autism; an Analysis of 50 Cases and a Consideration of Certain Relevant Neurophysiologic Concepts, J. Pediat., 57, 560, 10.1016/S0022-3476(60)80084-4

Amin, 1954, Distribution of Substance P and 5-Hydroxytryptamine in the Central Nervous System of the Dog, J. Physiol., 126, 603, 10.1113/jphysiol.1954.sp005229

McFarlane, 1956, Endocrine Aspects of Argentaffinoma, Scottish M. J., 1, 148, 10.1177/003693305600100402

Hawk, 1954, 889

Hardisty, 1955, 5-Hydroxytryptamine Concentration in Normal Human Platelets, J. Physiol., 130, 711, 10.1113/jphysiol.1955.sp005437

Kärki, 1959, The Influence of Iproniazid and Raunescine on the Penetration of 5-Hydroxytryptamine Into Brain Tissue From the Circulation, Acta pharmacol. et toxicol., 16, 20, 10.1111/j.1600-0773.1959.tb01184.x

Cargill-Thompson, 1958, Estimation of 5-Hydroxytryptamine in Blood and Serum, J. Physiol., 140

Correale, 1956, The Occurrence and Distribution of 5-Hydroxytrytamine in the Central Nervous System of Vertebrates, J. Neurochem., 1, 22, 10.1111/j.1471-4159.1956.tb12051.x

Blum, 1959, Oxidation of Serotonin and 5-Hydroxyindoles During Denaturation of Oxyhemoglobin, J. Biochem., 73, 530, 10.1042/bj0730530

Waalkes, 1959, The Determination of Serotonin (5-Hydroxytryptamine) in Human Blood, J. Lab. & Clin. Med., 53, 824

Davis, 1959, The Concentration of Serotonin in Normal Human-Serum as Determined by an Improved Method, J. Lab. & Clin. Med., 54, 344

Freedman, D. X., and Benton, A. J.: Persisting Effects of Reserpine in Man, New England J. Med. (in press).